Idexx Laboratories (IDXX) EV to EBITDA (2009 - 2026)
Idexx Laboratories (IDXX) posted EV to EBITDA of 97.11 for Q2 2026, down 20.56% on a QoQ basis from 122.24 in Q1 2026, and down 15.41% year-over-year from 114.79 in Q2 2025.
Analysis
Idexx Laboratories (IDXX) EV to EBITDA (2009 - 2026) Analysis & Trends
Idexx Laboratories has reported EV to EBITDA for 18 years, with the latest figure at 97.11 in Q2 2026.
- On a quarterly basis, EV to EBITDA fell 15.41% year-over-year to 97.11 in Q2 2026; TTM through Jun 2026 was 28.33, a 16.96% decrease from a year earlier, with the FY2025 full-year figure at 39.52, up 33.31% from the prior year.
- EV to EBITDA was 97.11 for Q2 2026 at Idexx Laboratories, down from 122.24 in the prior quarter.
- The five-year high for EV to EBITDA was 186.03 in Q4 2023, with the low at 97.11 in Q2 2026.
- Average EV to EBITDA over 5 years is 140.43, with a median of 141.93 recorded in 2025.
- The sharpest annual moves came in 2022 and 2025: EV to EBITDA slumped 52.77% in 2022, then jumped 33.23% in 2025.
- Over 5 years, EV to EBITDA stood at 148.79 in 2022, then advanced by 25.03% to 186.03 in 2023, then sank by 31.29% to 127.83 in 2024, then jumped by 33.23% to 170.3 in 2025, then plunged by 42.98% to 97.11 in 2026.
- The last three EV to EBITDA figures came in at 97.11 (Q2 2026), 122.24 (Q1 2026), and 170.3 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 97.11 |
| Mar 31, 2026 | 122.24 |
| Dec 31, 2025 | 170.30 |
| Sep 30, 2025 | 143.45 |
| Jun 30, 2025 | 114.79 |
| Mar 31, 2025 | 106.60 |
| Dec 31, 2024 | 127.83 |
| Sep 30, 2024 | 135.37 |
| Jun 30, 2024 | 150.80 |
| Mar 31, 2024 | 148.34 |
| Dec 31, 2023 | 186.03 |
| Sep 30, 2023 | 130.74 |
| Jun 30, 2023 | 140.41 |
| Mar 31, 2023 | 147.64 |
| Dec 31, 2022 | 148.79 |
| Sep 30, 2022 | 110.04 |
| Jun 30, 2022 | 162.77 |
| Mar 31, 2022 | 184.58 |
| Dec 31, 2021 | 278.81 |
| Sep 30, 2021 | 232.97 |